Ubs Group Ag I Bio, Inc. Transaction History

Ubs Group Ag

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$0.23 - $160.0 $12,069 - $8.4 Million	52,474 Added 2206.64%	54,852 $9,000
Q2 2022 Aug 10, 2022	SELL	$0.23 - $0.46 $8,366 - $16,732	-36,376 Reduced 93.86%	2,378 $1,000
Q1 2022 May 16, 2022	SELL	$0.3 - $0.61 $23,543 - $47,870	-78,477 Reduced 66.94%	38,754 $17,000
Q4 2021 Feb 14, 2022	BUY	$0.55 - $1.04 $64,477 - $121,920	117,231 New	117,231 $65,000
Q3 2021 Nov 15, 2021	SELL	$1.06 - $1.52 $24,723 - $35,452	-23,324 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$1.22 - $1.65 $32,674 - $44,190	-26,782 Reduced 53.45%	23,324 $35,000
Q1 2021 May 12, 2021	BUY	$1.18 - $2.62 $20,310 - $45,095	17,212 Added 52.33%	50,106 $77,000
Q4 2020 Feb 11, 2021	BUY	$1.05 - $2.24 $31,725 - $67,681	30,215 Added 1127.85%	32,894 $35,000
Q3 2020 Nov 12, 2020	SELL	$1.7 - $6.41 $22,043 - $83,118	-12,967 Reduced 82.88%	2,679 $5,000
Q2 2020 Jul 31, 2020	BUY	$0.87 - $2.46 $13,346 - $37,738	15,341 Added 5029.84%	15,646 $35,000
Q1 2020 May 01, 2020	SELL	$0.22 - $2.45 $21,596 - $240,506	-98,166 Reduced 99.69%	305 $0
Q4 2019 Feb 14, 2020	BUY	$0.11 - $0.58 $9,880 - $52,099	89,826 Added 1039.05%	98,471 $25,000
Q1 2019 May 14, 2019	SELL	$0.75 - $1.0 $3,459 - $4,612	-4,612 Reduced 34.79%	8,645 $8,000
Q4 2018 Feb 14, 2019	BUY	$0.57 - $1.05 $2,628 - $4,842	4,612 Added 53.35%	13,257 $10,000
Q3 2018 Nov 14, 2018	SELL	$0.64 - $0.91 $257 - $366	-403 Reduced 4.45%	8,645 $7,000
Q2 2018 Aug 14, 2018	BUY	$0.83 - $2.1 $7,509 - $19,000	9,048 New	9,048 $8,000

Ticker IBIO
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,006,580
Market Cap $23.8M
Description
iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.